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Introduction: During induction of general anesthesia, it is common practice 
to delay neuromuscular blockade until the ability to deliver mask ventilation 
has been confirmed, however, the benefits of this approach have never been 
scientifically validated. Thus, the early and late administration of rocuronium 
before and after checking mask ventilation were compared in patients with 
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normal airways. The time to tracheal intubation was also compared between 
groups. 
Methods: Patients (n = 114) were randomized to receive intravenous 
rocuronium either before (early rocuronium group, n = 58) or after (late 
rocuronium group, n = 56) checking mask ventilation. Expiratory tidal 
volumes were measured at 10, 20, 30, 40, 50, and 60 s after apnea during 
mask ventilation. The ease of mask ventilation was graded, and the time from 
apnea to tracheal intubation was measured. The primary outcome was the 
mean tidal volume for 60 s of mask ventilation after apnea. 
Results: The mean tidal volume was larger in the early rocuronium group 
than in the late rocuronium group for 60 s of mask ventilation after apnea  
[552 (165) ml breath
-1
 vs 393 (165) ml breath
-1
, mean difference (95% CI)  
160 ml breath
-1
 (98 to 221 ml breath
-1
), P < 0.001, unpaired t-test]. Because 
the interaction between time and group was significant in the tidal volumes 
measured for 60 s of mask ventilation (P < 0.001, linear mixed effects model), 
pairwise comparisons were performed at the six time points. The differences 
in tidal volumes between groups were significant at 10, 20, 30, 40 (P < 0.001 
each, unpaired t-test), and 50 s (P = 0.002) after apnea. The time to tracheal 
intubation was shorter in the early rocuronium group than in the late 
rocuronium group [116 (42) s vs 195 (41) s, mean difference (95% CI) -79 s  
(-96 to -64 s), P < 0.001]. 
Conclusions: The early administration of rocuronium before checking mask 
ventilation showed a larger tidal volume and earlier tracheal intubation than 
iii 
 
the late administration of rocuronium after checking mask ventilation in 
patients with normal airways. 
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After induction of general anesthesia, the patient cannot breathe 
spontaneously and thus requires assisted ventilation with a facemask. If the 
mask ventilation is difficult or impossible, a tracheal tube or supraglottic 
airway should be placed immediately to oxygenate the patient.
1-6
 The insertion 
of these devices can be facilitated by adequate neuromuscular blockade.
5-13
 
The performance of mask ventilation can also change before and after muscle 
relaxation.
1,4,14-20
 Nevertheless, during induction of general anesthesia, it is 
common practice to delay neuromuscular blockade until the ability to deliver 
mask ventilation has been confirmed. However, the benefits of this approach 
have never been scientifically validated.
1-4,14-17,21-25
 
Thus, this study compared the early and late administration of rocuronium 
before and after testing whether the operator was able to ventilate the lungs 
using a facemask in patients with normal airways. It was hypothesized that the 
early administration of rocuronium improves the efficiency of mask 
ventilation and shortens the time to tracheal intubation compared with the late 
administration. To objectively assess the efficiency of mask ventilation, 
expiratory tidal volumes during mask ventilation with pressure-controlled 
mechanical ventilation were measured. The primary outcome was the mean 
tidal volume for 60 s of mask ventilation after the onset of apnea and the main 
secondary outcome was the time from apnea to tracheal intubation, which was 






This prospective, double-blind, parallel-group, randomized controlled trial 
was approved by the Institutional Review Board of Seoul National University 
Hospital (reference number 1707-088-870) and written informed consent was 
obtained from all subjects participating in the trial. The trial was registered at 
ClinicalTrials.gov (NCT03270696, principal investigator: Jeong-Hwa Seo, 
Date of registration: 23 August 2017) prior to patient enrollment. This 
manuscript adheres to the applicable CONSORT guidelines. Inclusion criteria 
were patients aged > 20 years with ASA physical status I–III, and undergoing 
elective abdominal or gynecologic surgery under general anesthesia with 
orotracheal intubation between September 2017 and January 2018. Exclusion 
criteria were patients with risk of pulmonary aspiration, allergy to the study 
drugs, neuromuscular disorders, and predictors of difficult airway such as 
body mass index ≥ 35 kg m
-2
; Mallampati class 3 or 4; mass or radiation 
changes in the neck; limitations in mouth opening, neck extension, or jaw 
protrusion; and history of snoring or sleep apnea.
9,11,20,26,27
 
Patients were randomized into two groups to receive intravenous 
rocuronium either before (early rocuronium group) or after (late rocuronium 
group) checking mask ventilation. The allocation sequence was concealed in 
sealed opaque envelopes and patients were blinded to the group assignment. 
A nurse not involved in the study prepared 0.6 mg kg
-1
 of rocuronium 
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(Esmeron; MSD, Kenilworth, NJ) and the same volume of normal saline  
(JW Pharmaceutical, Seoul, Korea) in identical syringes. The syringe with 
rocuronium was labeled as the ‘first drug’ and the syringe with saline as the 
‘second drug’ in the early rocuronium group, and vice versa in the late 
rocuronium group. The anesthetic machine (Primus; Dräger, Lübeck, 
Germany) with the pressure gauge and spirometer was checked and calibrated. 
 
Anesthesia and mask ventilation 
Patients were monitored with pulse oximetry, non-invasive blood pressure, 
electrocardiography, and bispectral index (A-2000 XP; Aspect Medical 
Systems, Newton, MA). For the neuromuscular monitoring with 
acceleromyography (TOF-watch Sx; Organon, Dublin, Ireland), two 
electrodes were attached over the ulnar nerve of the patient’s left hand, a 
temperature sensor on the palm, and an acceleration transducer on the thumb 
with an elastic adaptor. Patients received forced-air warming (3M Bair 
Hugger, Eden Prairie, MN) to the whole body at a set temperature of 43℃ 
during anesthetic induction. The head was placed on a 7-cm height headrest in 
the supine position. 
For preoxygenation, 100% oxygen was supplied through a transparent 
facemask (900 series; Westmed, Tucson, AZ) at 10 L min
-1
, and patients 
breathed with tidal volumes for 3 min.
28
 While lactated Ringer’s solution  
(JW Pharmaceutical, Seoul, Korea) was dripping rapidly through an 18-gauge 
venous cannula in the forearm, lidocaine 30 mg was injected. After 10 s, 
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fentanyl 1 μg kg
-1
, propofol 2 mg kg
-1
, and the first drug was administered 
sequentially (Table 1). 
When the patient did not respond to verbal commands and eyelash reflex, 
the patient’s nose and mouth were sealed with the facemask by using the left 
hand. The mask was held by the left thumb and index finger forming a     
C-shape, and its elastomeric cushion created an airtight seal with the patient’s 
face. The left third and fourth fingers were placed on the mandible body and 
the fifth finger was on the mandible angle to extend the patient’s head and to 
thrust the jaw. The anesthetic machine was set to deliver pressure-controlled 
ventilation with a peak inspiratory pressure of 15 cmH2O, a positive end-
expiratory pressure of 5 cmH2O, a respiratory rate of 12 breaths min
-1
, and an 
inspiratory-expiratory ratio of 1:2. Sevoflurane 4-6% was supplied with 100% 
oxygen of 6 L min
-1
. End-tidal carbon dioxide was measured with a 
sidestream capnometer (Dräger, Lübeck, Germany). 
After adequate mask ventilation was confirmed by the chest movement 
and upslope of the capnogram, the second drug was given and mask 
ventilation continued (Table 1). Train-of-four (TOF) count was monitored at 
the adductor pollicis muscle every 15 s. 
At a TOF count of 0 and bispectral index of < 60, the patient’s trachea 
was intubated via direct laryngoscopy with a Macintosh 3 or 4 blade. If the 
intubation failed, it was retried with direct or video laryngoscopy (C-MAC; 
Karl Storz, Tuttlingen, Germany) after the tube was shaped like a hockey stick 
with a stylet. An inner diameter of the tracheal tube (Covidien, Mansfield, 
MA) was 7.0 mm for women and 7.5 mm for men. Tracheal intubation was 
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verified by the chest movements and a square-wave capnogram. The tracheal 
cuff pressure was adjusted to less than 25 cmH2O. 
If mask ventilation or tracheal intubation were impossible, the patient 





Table 1. The study protocol 
 Preoxygenation for 3 min 
 Intravenous injection of lidocaine 30 mg 
 Administration of fentanyl 1 μg kg
-1
 and propofol 2 mg kg
-1
 
 Administration of the first drug
a
 
 Detection of apnea and unconsciousness 
 Mask ventilation checked with pressure-controlled mode 
 Mask ventilation confirmed by chest movements and capnogram 
 Administration of the second drug
a
 
 Monitoring of train-of-four count = 0 and bispectral index < 60 
 Start of direct laryngoscopy 
 End of laryngoscopy 
 Tracheal intubation confirmed by chest movements and capnogram 
 
a 
The first and second drugs are 0.6 mg kg
-1
 of rocuronium and the same 
volume of normal saline in the early rocuronium group, respectively, and vice 





During the injections of the first and second drugs, the patient’s withdrawal 
movements were graded into four levels: no response, movement of the wrist 
only, movement of the elbow or shoulder, and movement in more than one 
extremity and reactions such as discomfort or pain.
29
 
During mask ventilation, expiratory tidal volumes, end-tidal 
concentrations of sevoflurane, and bispectral index values were recorded at 10, 
20, 30, 40, 50, and 60 s after detecting apnea. The tidal volume and 
sevoflurane concentrations were measured with the spirometer and gas 
analyzer incorporated in the anesthetic machine. The minute volume and the 
average of tidal volumes for 60 s of mask ventilation were calculated. Mask 
ventilation was evaluated with a four-point scale: easy ventilation, moderate 
ventilation with an oropharyngeal airway, difficult ventilation requiring two 
providers, and impossible ventilation by any methods.
9,11,18,19,27,30,31
 
During tracheal intubation, the ease of laryngoscopy, movement or 
position of the vocal cords, limb movement, and coughing were assessed and 
each variable was scored as excellent, good or poor conditions. The overall 
intubation condition was excellent if all variables were excellent, good if all 
were excellent or good, and poor if any variable was poor.
10,32
 Mean blood 
pressure and heart rate were recorded immediately before intubation and one 
minute after intubation. The time from apnea to successful intubation and the 
time for laryngoscopy were measured. The laryngoscopic time was defined as 
the interval between insertion and removal of the laryngoscope blade in the 
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mouth. After surgery, patients were transferred to the postanesthesia care unit 
and were asked whether they had experienced muscle weakness during 
anesthetic induction. 
To quantify the efficiency of mask ventilation, the mean expiratory tidal 
volume for 60 s after apnea was calculated as the primary outcome. The 
secondary outcomes were the tidal volume, sevoflurane concentrations, and 
bispectral index at each measurement time point, minute volume, grade of 
mask ventilation, time from apnea to intubation, intubation conditions, 




The distribution of all continuous data was compatible with a normal 
distribution and the data are presented as mean (SD). Continuous variables 
including the primary outcome were compared with unpaired t-tests. 
Repeatedly measured outcomes were analyzed with linear mixed effects 
models. A random effect was the subject and fixed effects were time (as a 
categorical variable), group, and interaction between the time and group. If 
the interaction was significant, pairwise comparisons were performed at each 
time point with unpaired t-tests. If no interaction was detected, the main effect 
of group collapsing over time was reported. A first-order autoregressive 




Categorical variables were presented as a number of patients and were 
compared with Pearson chi-square test or Fisher’s exact test if the expected 
frequencies were less than 5. A significance criterion was P < 0.05 for two-
sided analysis and was adjusted to P < 0.008 (= 0.05/6) with the Bonferroni 
correction for pairwise comparisons at the six time points. Mean differences 
with 95% CIs were calculated for the primary outcome and the secondary 
outcomes including the tidal volume at each time point, minute volume, and 
the time from apnea to intubation. 
In the pilot study for patients with normal airways (n = 10), the mean tidal 
volume for 60 s after apnea was 341 (186) ml breath
-1
 when rocuronium was 
given after checking mask ventilation with the pressure-controlled mode. 
Considering a 30% difference in the tidal volume, 53 patients were needed in 
each group with an α of 0.05 and a power of 0.8 for two-sided analysis. 
STATA (Special Edition 14.2; Stata Corporation, College Station, TX) was 







After screening 116 patients, 114 patients were randomized to the early     
(n = 58) and late (n = 56) rocuronium groups. Some data were missed at 50 
and 60 s after apnea because mask ventilation ended before these time points 
(Fig. 1). There were no apparent clinically important differences in baseline 
patient characteristics (Table 2). By using the linear mixed effects model,  
no significant differences were found in the sevoflurane concentrations       
(P = 0.241 for the interaction between time and group; P = 0.317 for the main 
effect of group collapsing over time) and the bispectral index values       
(P = 0.758; P = 0.860) during mask ventilation. 
Mask ventilation was easy or moderate in all patients. For 60 s of mask 
ventilation after apnea, the mean tidal volume (primary outcome, P < 0.001) 
and minute volume (P = 0.001) were larger in the early rocuronium group 
than in the late rocuronium group (Table 3). Because the interaction between 
time and group was significant in the tidal volumes measured for 60 s of mask 
ventilation (P < 0.001), pairwise comparisons were performed at the six time 
points. The differences in the tidal volume were significant at 10, 20, 30, 40, 
and 50 s after apnea between groups (Fig. 2). No differences were found in 
the grade of mask ventilation and response to rocuronium injection (Table 3). 
Tracheal intubation was achieved with direct laryngoscopy at the first attempt 
and the intubation condition was excellent or good in all patients. The time 
from apnea to intubation was shorter in the early rocuronium group than in the 
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late rocuronium group (Table 3; P < 0.001). There were no differences in the 
laryngoscopic time, intubation conditions, and blood pressure or heart rate 
before and after intubation (Table 3). No patient had any complications or the 




Table 2. Patient characteristics and drug doses for anesthetic induction 
 
Early rocuronium 
group (n = 58) 
Late rocuronium 
group (n = 56) 
Age (year) 57 (12) 59 (12) 
Female 25 33 
Weight (kg) 62 (11) 61 (12) 
Height (cm) 163 (8) 162 (9) 
Body mass index (kg m
-2
) 23.2 (3.0) 23.1 (3.3) 
ASA physical status (I/II) 27/31 21/35 
Mallampati class (1/2) 42/16 45/11 
Fentanyl (μg) 60 (9) 59 (10) 
Propofol (mg) 123 (18) 120 (20) 
Rocuronium (mg) 36 (5) 34 (6) 
 





Table 3. Outcomes during mask ventilation and tracheal intubation 
 
Early rocuronium 
group (n = 58) 
Late rocuronium 
group (n = 56) 
P-value 




 552 (165) 393 (165) < 0.001 




 5.8 (2.3) 4.5 (1.9) 0.001 
Grade of mask ventilation (easy/moderate) 53/5 54/2 0.439 
Response to rocuronium injection  
(none/wrist movement) 
54/4 51/5 0.740 
Laryngoscopic time (s) 17 (13) 16 (5) 0.612 
Time from apnea to intubation (s)
c
 116 (42) 195 (41) < 0.001 
Cormack-Lehane grade (1/2) 49/9 53/3 0.125 
Intubation conditions (excellent/good) 53/5 49/7 0.500 
Ease of laryngoscopy (excellent/good) 57/1 54/2 0.615 
Movement or position of the vocal cords 
(excellent/good) 
55/3 53/3 > 0.999 
Limb movement (excellent/good) 57/1 53/3 0.360 
Coughing (excellent/good) 53/5 49/7 0.500 
Mean blood pressure before intubation (mm Hg) 87 (18) 93 (19) 0.095 
Mean blood pressure after intubation (mm Hg) 101 (21) 98 (15) 0.994 
Heart rate before intubation (beats min
-1
) 73 (13) 75 (13) 0.375 
Heart rate after intubation (beats min
-1
) 75 (14) 78 (12) 0.217 
 
Data are the number of patients or mean (SD).  
a 
The average of expiratory tidal volumes for 60 s of mask ventilation after apnea. 
Mean difference (95% CI) 160 ml breath
-1
 (98 to 221 ml breath
-1
), unpaired t-test;  
b 
For 60 s of mask ventilation after apnea. 1.3 L min
-1















Figure 2. Expiratory tidal volumes during mask ventilation at 10, 20, 30, 40, 
50, and 60 s after apnea. The circle is mean and the error bar is SD. The 
significance criterion is P < 0.008 (= 0.05/6) for pairwise comparisons at the 
six time points. 
*Mean difference (95% CI) 230 ml (158-302 ml), P < 0.001 compared with 
the late rocuronium group, unpaired t-test;  
†
232 ml (160 to 304 ml), P < 0.001;  
‡
194 ml (122 to 267 ml), P < 0.001;  
§
154 ml (77 to 230 ml), P < 0.001;  
¶





This study showed larger tidal volumes during mask ventilation with pressure-
controlled mechanical ventilation and earlier tracheal intubation in the early 
rocuronium group than in the late rocuronium group. 
There are controversies about the effects of neuromuscular blockade on 
mask ventilation.
1,4,14-20,33,34
 Three crossover studies
19,20,31
 reported larger tidal 
volumes after giving rocuronium or vecuronium, but another two crossover 
studies
33,34
 found no difference in the tidal volumes before and after giving the 
muscle relaxants. However, these studies did not randomize the order of 
comparative interventions, and neuromuscular blockade was achieved later 
when anesthesia was more profound. Anesthetic depth is known to affect 
mask ventilation
19,20,31,35,36
 and thus may bias these previous findings. 
Moreover, a previous randomized study
18
 only compared neuromuscular 
blockade with no blockade although muscle relaxants are almost always used 
for mask ventilation before tracheal intubation. Thus, this study was designed 
with a randomized parallel-group trial and compared the different timing of 
neuromuscular blockade under no significant difference in the anesthetic 
depth as shown by the sevoflurane concentration and bispectral index during 
mask ventilation. This study supports the previous findings that 
neuromuscular blockade increases tidal volume during mask ventilation.
18-20,31
 
Atelectasis may develop after the induction of general anesthesia
37
 and 
be aggravated by lower tidal volume.
38
 In this study, the mean tidal volume 
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for 60 s of mask ventilation was 160 ml larger in the early rocuronium group 
than in the late rocuronium group. In addition, a larger minute volume of   
1.3 L min
-1
 was observed in the early rocuronium group, which is about three 
times greater than the oxygen consumption of a healthy subject.
28
 Therefore, 
the larger tidal volume and minute volume during mask ventilation might be 
beneficial to patients with high risk of atelectasis formation or low oxygen 
reserve, although these outcomes were not directly investigated. 
The conventional practice of delaying neuromuscular blockade after 
checking mask ventilation seems to be based on the strategy to wake up the 
patient rapidly in unanticipated difficult mask ventilation.
3,4,15,16,23-25
 However, 
this strategy may be impractical
4,9,11,15,16,23,26
 because the duration of hypnotics 
is not short enough to restore the patient’s spontaneous breathing without the 
risk of hypoxemia.
39
 The relevant rescue for impossible mask ventilation is 
thus not to wait for the spontaneous breathing without any action but to place 
a tracheal tube or supraglottic airway as soon as possible with a minimum 
number of attempts.
1-6
 The rescue intervention is more successful with 
adequate neuromuscular blockade than without blockade.
5-13
 After detecting 
apnea, it was able to intubate the patient’s trachea more rapidly in the early 
rocuronium group than in the late rocuronium group with no significant 
differences in intubation conditions and hemodynamic changes during 
laryngoscopy. Although it was not an emergency situation, these findings 
suggest that the early administration of rocuronium may provide optimal 
intubating conditions earlier than the late administration to rescue patients 




As a secondary outcome, mask ventilation was graded using a four-point 
scale described in previous studies.
9,11,18,19,27,30,31
 This can clinically classify 
easy and difficult mask ventilations
9,11,27,30
 but be less sensitive in patients 
with normal airways.
18,19,31
 This may explain why mask ventilation was 
graded as easy or moderate in all patients and was not significantly different 
between groups in this present study. Therefore, as the primary outcome, the 
expiratory tidal volume was measured to quantify the efficiency of mask 
ventilation as in previous studies.
19,20,31,33,34
 Although manual ventilation is 
more common during anesthetic induction, pressure-controlled ventilation 
was provided to generate constant inflation pressure so that the tidal volume 
objectively reflects the efficiency of mask ventilation.
19,20,34
 However, unlike a 
previous study using two hands for mask ventilation,
19
 the one-hand technique 
was applied to simulate the real practice. In addition, the anesthesiologist who 
performed the mask ventilation was completely blinded to the treatment group 
in order to minimize performance bias. 
When rocuronium is given intravenously in light anesthesia, it can cause 
a burning pain and withdrawal movements in the injection site because of its 
low pH.
29,40,41
 The injection pain can be reduced by intravenous pretreatment 
of lidocaine 30 mg
40,41
 as used in this study. This may explain no difference in 
response to the rocuronium injection between groups although rocuronium 
was given earlier with a lighter anesthetic state in the early rocuronium group. 
The patient may also complain of muscle weakness if rocuronium is given 
before complete loss of consciousness after the administration of propofol. 
１９ 
 
However, it was found that no patient recalled muscle weakness during 
anesthetic induction. This was probably because a high dose of propofol     
2 mg kg
-1
, used for rapid sequence induction
42
, and a conventional dose of 
rocuronium 0.6 mg kg
-1 
were administered. 
Although larger tidal volumes and earlier tracheal intubation were 
observed in the early rocuronium group, neuromuscular blockade before 
checking mask ventilation should be carefully considered depending on the 
clinical situation. It is appropriate to wait before delivering a neuromuscular 
blocker when the insertion of a supraglottic airway fails, or the upper airway 
examination or fiberoptic intubation are planned without muscle relaxation. 
On the other hand, difficult or impossible mask ventilation caused by 
laryngospasm can be best managed by neuromuscular blockade.
3
 
This study has limitations. During anesthetic induction, the timing of 
neuromuscular blockade may be more important in patients with difficult 
airways, but these patients were excluded because of patient safety. The 
sample size of this study was also too small to compare adverse events 
between groups. In addition, the acceleromyograph was not calibrated in order 
to give rocuronium immediately after propofol without delay. However, the 
TOF count may be reliable without calibration because the four responses are 
amplified equally,
43
 so it was unlikely to bias these findings. Also, the interval 
between injections of the first and second drugs was not measured, but it is 
only assumed that it would be similar to the difference of the time to tracheal 
intubation between groups. 
In conclusion, larger tidal volumes during mask ventilation and earlier 
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tracheal intubation were shown in the early rocuronium group than in the late 
rocuronium group. Because the expiratory tidal volume can increase after 
neuromuscular blockade,
18-20,31
 its evaluation before the blockade may lead to 
a wrong decision for the subsequent airway management. Adequate muscle 
relaxation is also required to optimize the conditions for tracheal intubation 
whether mask ventilation is possible or impossible.
5,6,9,11
 Therefore, the 
administration of rocuronium before checking mask ventilation may be 
considered to provide larger tidal volumes and earlier tracheal intubation 
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요약 (국문 초록) 
 
서론 : 전신마취 유도 도중 신경근차단제 투여가 마스크 환기 가능 
여부를 확인할 때까지 지연되는 것은 흔한 일이나, 이러한 접근의 
이점은 과학적으로 입증된 바가 없다. 따라서, 정상 기도를 가진 
환자들에서 마스크 환기 확인 전후에 로큐로니움을 투여했을 때 
마스크 환기 효율이 차이가 나는지 비교하였다. 
 
방법 : 총 114 명의 환자들 중 58 명이 마스크 환기 확인 전 
로큐로니움을 정주한 조기 투여군, 56 명이 확인 후 정주한 지연 
투여군으로 무작위 배정되었다. 마스크 환기 동안 호기말 
일회호흡량을 무호흡 후 10, 20, 30, 40, 50, 60 초 후 측정하였다.  
또한, 마스크 환기의 용이함에 등급을 나누고 무호흡부터 기관 
삽관까지의 시간을 측정하였다. 
 
결과 : 무호흡 후 60 초 동안의 평균 일회호흡량은 로큐로니움 조기 
투여군에서 지연 투여군보다 크게 나타났다[호흡당 552 (165) ml vs 
393 (165) ml, 평균차 (95% 신뢰구간) 호흡당 160 ml (호흡당 98,   
221 ml), P < 0.001, unpaired t-test]. 60 초 동안의 마스크 환기 동안 
측정된 일회 호흡량에서 시간-군과의 상호작용이 유의하였기 
２８ 
 
때문에 (P < 0.001, 선형 혼합 효과 모델), 6 개 시점에서 짝비교를 
수행하였다. 양 군의 일회호흡량 차이는 무호흡 후 10, 20, 30, 40   
(P < 0.001 each, unpaired t-test), 50 초 (P = 0.002)에서 유의하였다. 기관 
삽관까지의 시간은 로큐로니움 조기 투여군에서 지연 투여군보다 
짧았다[116 (42) 초 vs 195 (41) 초, 평균차 (95% 신뢰구간) -79 초 (-96, 
-64 초), P < 0.001]. 
 
결론 : 정상 기도를 가진 환자들에서 마스크 환기 확인 전 
로큐로니움을 투여한 군이 확인 후 투여한 군보다 큰 일회호흡량을 
보였고, 기관 삽관도 더 빨랐다. 
 
주요어 : 마스크 환기, 로큐로니움, 일회호흡량, 기관 삽관 
학번 : 2017-29965 
